Newsroom | 12251 results

Sorted by: Latest

Surgery
-

Alcon Publishes Agenda for 2026 Annual General Meeting

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2026 Annual General Meeting...
-

Alcon Publishes Agenda for 2026 Annual General Meeting

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2026 Annual General Meeting...
-

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro...
-

Dr. Adam Scheiner Wins Best Surgical Facial Rejuvenation Again at AMWC Monaco

TAMPA, Fla.--(BUSINESS WIRE)--Dr. Adam Scheiner, a world-renowned laser eyelid and facial cosmetic surgeon, has again received international recognition at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco. Dr. Scheiner won the Best Surgical Facial Rejuvenation award for the second consecutive year, recognized for his innovative laser-based methods to treat complex under-eye concerns, rejuvenate the delicate eyelid area and achieve full-face transformation. Selected throug...
-

Epia Neuro Launches to Develop Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

SAN FRANCISCO--(BUSINESS WIRE)--Epia Neuro Launches to Develop Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline...
-

restor3d Announces Full Commercial Release of the Aeros™ Modular Stem System

DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in 3D-printed, personalized orthopedic solutions, today announced the full commercial availability of the Aeros™ Modular Stem System, an advancement in stemmed total ankle replacement designed to enhance implant stability, preserve bone, and improve surgical efficiency. The system follows a successful limited market release that began May 5, 2025, during which more than 250 procedures were completed across 50+ unique surgeons with strong feedbac...
-

Shape Memory Medical Begins Enrollment in FLAGSHIP Study Evaluating Novel False Lumen Embolization Technology

SAN JOSE, Calif.--(BUSINESS WIRE)--Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular applications, today announced enrollment of the first patients in FLAGSHIP, the Company’s prospective, single‑arm, open‑label first‑in‑human study evaluating its investigational False Lumen Embolization (FLE) System for the treatment of aortic dissection. Aortic dissection is a life‑threatening condition in which a tear in the aortic wall creates a secondary channel known as...
-

Children’s Hospital Los Angeles Celebrates 125 Years: From One Doctor on Horseback to Global Pediatric Leader

LOS ANGELES--(BUSINESS WIRE)--Children’s Hospital Los Angeles (CHLA) is marking its 125th anniversary, celebrating more than a century of advances in pediatric medicine through clinical excellence, surgical innovation, and scientific discovery. CHLA consistently ranks among the nation’s top 10 children’s hospitals on U.S. News & World Report’s Honor Roll of Best Children’s Hospitals, earning international recognition as a destination for families seeking specialized pediatric care. Incorpor...
-

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported financial results for the quarter and year ended December 31, 2025, and provided a business update. Business Update Initiated Evaluation of Strategic Alternatives On March 25, 2026, the Company announced that its Board of Directors has initiated a process to evaluat...
-

MTF Biologics® and Kolosis BIO® Launch the Latest Addition to the DBX Family: DBX® Fiber

EDISON, N.J. & SALT LAKE CITY--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis®, an industry leading pure-play surgical biologics company, today announced the launch of DBX Fiber®, the latest addition to the DBX® family. For decades, DBX has been a trusted name in demineralized bone matrix, earning its reputation through proven performance in operating rooms around the w...